• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Managing Patients With Homozygous Familial Hypercholesterolemia.

作者信息

Gidding Samuel S

机构信息

A. I. DuPont Hospital for Children, Wilmington, Delaware.

出版信息

J Am Coll Cardiol. 2017 Aug 29;70(9):1171-1172. doi: 10.1016/j.jacc.2017.06.057.

DOI:10.1016/j.jacc.2017.06.057
PMID:28838367
Abstract
摘要

相似文献

1
Managing Patients With Homozygous Familial Hypercholesterolemia.管理纯合子家族性高胆固醇血症患者。
J Am Coll Cardiol. 2017 Aug 29;70(9):1171-1172. doi: 10.1016/j.jacc.2017.06.057.
2
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.瑞舒伐他汀在杂合子家族性高胆固醇血症儿童中的疗效及其与潜在遗传突变的关系。
J Am Coll Cardiol. 2017 Aug 29;70(9):1162-1170. doi: 10.1016/j.jacc.2017.06.058.
3
The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.低密度脂蛋白受体基因型是纯合子家族性高胆固醇血症患者进行脂蛋白分离术后低密度脂蛋白胆固醇浓度反弹的重要决定因素。
Circulation. 2017 Aug 29;136(9):880-882. doi: 10.1161/CIRCULATIONAHA.117.029435.
4
First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.首例因低密度脂蛋白受体基因突变导致的阿曼家族性高胆固醇血症病例报告。
Angiology. 2013 May;64(4):287-92. doi: 10.1177/0003319712465171. Epub 2012 Nov 15.
5
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.瑞舒伐他汀治疗儿童和青少年家族性高胆固醇血症的疗效与安全性：CHARON研究结果
J Clin Lipidol. 2015 Nov-Dec;9(6):741-750. doi: 10.1016/j.jacl.2015.07.011. Epub 2015 Aug 1.
6
Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia.PCSK9 单克隆抗体 AMG 145 对家族性高胆固醇血症纯合子患者的疗效。
Circulation. 2013 Nov 5;128(19):2113-20. doi: 10.1161/CIRCULATIONAHA.113.004678. Epub 2013 Sep 6.
7
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.洛美他派对家族性高胆固醇血症患者心血管结局指标的影响：模型分析。
Eur J Prev Cardiol. 2017 Nov;24(17):1843-1850. doi: 10.1177/2047487317730473. Epub 2017 Sep 19.
8
Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.降脂治疗的进展降低了家族性高胆固醇血症纯合子患者的死亡率。
Circulation. 2011 Nov 15;124(20):2202-7. doi: 10.1161/CIRCULATIONAHA.111.042523. Epub 2011 Oct 10.
9
Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.西班牙的纯合子家族性高胆固醇血症：患病率及表型-基因型关系
Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.
10
Familial homozygous hypercholesterolemia: report of two patients and review of the literature.家族性纯合子高胆固醇血症：两例患者报告及文献复习
Pediatr Dermatol. 2007 May-Jun;24(3):230-4. doi: 10.1111/j.1525-1470.2007.00391.x.

引用本文的文献

1
Case of homozygous familial hypercholesterolaemia with premature coronary artery disease.家族性高胆固醇血症纯合子病例伴发早发冠状动脉疾病。
BMJ Case Rep. 2021 May 19;14(5):e242114. doi: 10.1136/bcr-2021-242114.
2
Minimizing the risk of perioperative cardiovascular complications in homozygous familial hypercholesterolemia: a case report.降低纯合子家族性高胆固醇血症患者围手术期心血管并发症风险：一例报告
J Dent Anesth Pain Med. 2020 Feb;20(1):39-44. doi: 10.17245/jdapm.2020.20.1.39. Epub 2020 Feb 28.
3
A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH).
一种新型简化的家族性高胆固醇血症中国标准（SCCFH）修正系统。
Mol Diagn Ther. 2019 Aug;23(4):547-553. doi: 10.1007/s40291-019-00405-1.